Navigation Links
Therapeutic in Biological Technology

GeoVax Labs, Inc. Provides Clinical Studies Update

... 30% of the projected participants. On the therapeutic front, we are in the midst of planning the ... sites in Iquitos and Miraflores (Lima). therapeutic Clinical Trials - Planning for Phase 1 To help ... with HIV, the Company is preparing for a Phase 1 therapeutic trial to start in early 2010. "The goal here is ...

ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery

... Holdings Plc (SCLP.PL), which is developing therapeutic cancer and infectious disease vaccines. This ... licensing and strategic partnering to develop therapeutic cancer and infection disease vaccines. In 2008, ... . Scancell is developing novel therapeutic vaccines for the treatment of cancer and ...

The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.

... for ongoing use in clinical trials and other therapeutic treatments at the National Institutes of Health ... committed to supporting clinical research in key therapeutic areas for more than 50 years, and this ... play a crucial role in evaluating potential therapeutic treatments for many critical health challenges ...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

... portfolio and broaden our commercial focus into therapeutic areas that complement our leadership position in ... will find Intermezzo ((R)) to be a valuable therapeutic option for managing patients with ... of proprietary products that address important therapeutic needs in neuroscience. For further ...

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

... view of the safety profile of Restanza, the therapeutic need for more effective treatments for CAP and ... program. We believe that Restanza has significant therapeutic and commercial potential as a novel agent to ... and commercialization of novel drugs in the therapeutic areas of infection, cancer, respiratory diseases ...

Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors

... technology platform is designed to provide a therapeutic level of protein synthesis at a specific site in ... or DNA vector encoding for a growth factor or any therapeutic protein. The Gene Activated Matrix technology ... quantities of growth factor proteins or other therapeutic proteins based on the protein-producing DNA of ...

Sangamo BioSciences Reports Second Quarter 2009 Financial Results

... Presentation of positive Phase 2 ZFP therapeutic data at ADA 2009. Sangamo announced the ... finger DNA-binding protein (ZFP) technology for therapeutic gene regulation and modification. By engineering ... to evaluate safety and clinical effect of a ZFP therapeutic for the treatment of HIV/AIDS. ...

ImmuneRegen BioSciences Confirms Homspera's Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration

... both active on oral administration and provides therapeutic effects against the current pandemic H1N1 virus ... immune system activation, and expands the therapeutic range over which activity of the compound has ... that oral administration of Homspera results in therapeutic effects. This suggests appropriate oral ...

Sanofi-aventis Announces Second Quarter 2009 Results

... of the CURRENT/OASIS-7 study, evaluating a new therapeutic regimen involving high doses of Plavix(R) versus ... company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. ... the future approval and commercial success of therapeutic alternatives, the Group's ability to benefit from ...

Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer

... 600 people and 500 active projects spanning all therapeutic areas. Previously, he was Senior Vice President, ... for Phase I-III trials in a broad spectrum of therapeutic areas. He holds a Doctorate in Philosophy from ... access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical ...

Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast

... finger DNA-binding protein (ZFP) technology for therapeutic gene regulation and modification. By engineering ... to evaluate safety and clinical effect of a ZFP therapeutic for the treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, ...

Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics

... interference (RNAi) Technology for novel targeted therapeutic development. The company's multi-targeted siRNA therapeutic programs utilizing its nanoparticle-enhanced ... the enthusiasm for the great promise of siRNA therapeutic development. There are more than a dozen clinical ...

Regado Biosciences Expands Medical Advisory Board

... company leading the development of antithrombotic therapeutic aptamers with active control agents, today ... Regado Biosciences is pioneering a new therapeutic technology with the creation and development of ... improved safety profiles and a greater degree of therapeutic control. Regado's technology is designed to give ...

Hygeia Therapeutics Signs an Exclusive License with Yale University for Potent, Safe Topical Anti-Androgens

... and efficacious topical hormone modulators in the therapeutic areas of dermatology and women's health." ... at or near the site of application after the therapeutic purpose is achieved. By avoiding the formation ... a better safety profile than other drugs in their therapeutic class. Hygeia assets were obtained by an ...

Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes

... organization with a strong management team and therapeutic and regulatory expertise, is in the best interest ... device development programs. Encorium offers therapeutic expertise, experienced team management and ... trial experience across a wide variety of therapeutic areas such as infectious diseases, ...

Morphotek(R), Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies

... possible development as we continue to grow our therapeutic antibody portfolio." "CII has developed ... or develop new antibodies for potential therapeutic applications. About Cancer ... platform on the development and manufacturing of therapeutic antibodies for the treatment of cancer, ...

New drugs faster from natural compounds: A UC San Diego breakthrough

... "Natural products have a long history in therapeutic development and many were discovered before the ... identified. "As long as the structure of the therapeutic or a related therapeutic or natural product is in the library, we can ...

Monitoring Circulating Tumor Cells With the CellSearch(R) System Can Predict Prognosis in Metastatic Breast Cancer

... are two of the most promising new tools for therapeutic monitoring in patients with MBC. The number of ... of integrating the CellSearch(R) CTC test in therapeutic monitoring of patients with metastatic disease." ... category, detection of five or more CTCs during therapeutic monitoring accurately predicted prognosis in MBC ...

iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming

... to translate our stem cell research efforts into therapeutic realities for patients. Our initial focus will ... and cardiovascular diseases, as well as other therapeutic areas." iPierian has secured a $10 million ... new molecular targets and develop proprietary therapeutic small molecule or biologic drugs for its own ...

VisEn Launches New Cat-K FAST(TM) Fluorescence Molecular Imaging Agent

... activity associated with disease progression and therapeutic response in vivo . Cathepsin K expression is well known as a key biomarker and therapeutic target in a range of bone-related diseases, ... and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo . VisEn's FMT systems and ...

Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome

... with carcinoid syndrome currently have limited therapeutic options, and the standard of care includes ... clinical development of LX1032 and the potential therapeutic and commercial potential of LX1032. This press ... intellectual property rights, and the therapeutic or commercial value of its drug candidates, ...

Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business

... device development programs. Encorium offers therapeutic expertise, experienced team management and ... trial experience across a wide variety of therapeutic areas such as infectious diseases, ... in the design of complex clinical trials, its therapeutic experience and commitment to excellence, and its ...

Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease

... BioPharma Corporation to express and develop therapeutic monoclonal antibodies for the potential treatment ... and its expertise to produce and develop a therapeutic monoclonal antibody. SEP(TM) is an integrated ... optimized for affinity and/or titer, for therapeutic applications and high-titer manufacturing cell ...

PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin

... occurs naturally in humans. When attached to a therapeutic protein, CTP extends the time that the protein is ... for additional CTP-enhanced long-acting therapeutic proteins and peptides that are currently pending. ... to extend the duration of action of other therapeutic proteins. CTP was discovered at Washington ...

Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

... largest and the fastest growing prescription drug therapeutic class. Respiratory Agents market represents the second largest therapeutic class in 2009, followed closely by Lipid ... Detailed discussions on leading drugs by therapeutic class, patent expiries of major drugs, review of ...

Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals

... (PK) assays in the development of therapeutic proteins. Per Carendi, CEO of SLS Invest, ... process development and in clinical evaluation of therapeutic proteins. The ease of assay transfer is ... pharmacokinetic (PK) assays in the development of therapeutic proteins. Many major pharmaceutical ...

NeoStem Featured in Business Week; 'Promising' Adult Stem Cell Market Discussed in Fortune-CNNMoney.com Article

... of the driving power of NeoStem's adult stem cell therapeutic development initiatives. We have achieved ... can be attributed to our expansion in the therapeutic arena as evidenced by recent licensing of stem ... licensed certain stem cell technology in the therapeutic areas of orthopedics, wounds and skin ...

Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer

... breast cancer. Stimuvax is an investigational therapeutic cancer vaccine being developed by Merck KGaA ... Stimuvax Stimuvax is an investigational therapeutic cancer vaccine designed to induce an immune ... specializing in the development of innovative therapeutic products for the treatment of cancer. ...

Modigene Shareholders Approve Company Name Change and Other Proposals at Annual Meeting

... the longevity and biological activity of major therapeutic proteins such as follicle stimulating hormone, ... VII and Factor IX, and potentially any other therapeutic protein," said Shai Novik, president of PROLOR ... proprietary versions of already approved therapeutic proteins that currently generate billions of ...

HUYA Bioscience Announces Strategic Collaboration With the Shenyang Pharmaceutical University

... University. The agreement covers a wide range of therapeutic areas and represents one of the first official ... review and negotiation relating to certain novel therapeutic compounds owned or controlled by the University. ... largest Chinese compound portfolio covering all therapeutic areas, HUYA has emerged as the partner-of-choice ...

Intarcia Therapeutics, Inc. Presents ITCA 650 Phase 1b Study Results as a Late-Breaker at the American Diabetes Association 69th Scientific Sessions

... goals of the ITCA 650 program are to enhance the therapeutic effects of exenatide by ensuring patient compliance and providing more consistent, round-the-clock therapeutic drug levels; and to reduce side effects, ... technology that maintains stability of therapeutic proteins and peptides at human body temperature ...

Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference

... and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most ... to evaluate safety and clinical effect of a ZFP therapeutic for the treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, ...

Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma

... to explore a new path in the pursuit of a therapeutic treatment for patients with blood cancers. Cord ... blood stem/progenitor cells, increasing their therapeutic capacity for transplantation in adolescents and ... leader in stem cell expansion technologies and therapeutic products. The company is developing a pipeline of ...

Regado Biosciences Establishes Medical Advisory Board

... company leading the development of antithrombotic therapeutic aptamers with active control agents, today ... Regado Biosciences is pioneering a new therapeutic technology with the creation and development of ... is comprised of a nuclease-stabilized RNA aptamer therapeutic that can be controlled directly by its specific ...

Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use

... makes transplanted cells visible by MRI. therapeutic cells are labeled ex vivo with the Cell Sense ... track the administration and migration of therapeutic and/or diagnostic cells using 19F MRI or MRS. ... a surrogate biomarker for certain cellular therapeutic and drug trials. About Celsense, Inc. ...

Results From Neurotech's NT-501 Phase 2 Retinitis Pigmentosa Studies Demonstrate Consistent Biological Effect on Photoreceptors

... healthy, viable cells that continue to produce therapeutic levels of CNTF. This is consistent with data from ... of our ECT platform to deliver a variety of therapeutic factors in a consistent, long-term and ... NT-501 is designed to continually deliver a therapeutic dose of CNTF into the back of the eye. ...

Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions

... goals of the ITCA 650 program are to enhance the therapeutic effects of exenatide by ensuring patient compliance and providing more consistent, round-the-clock therapeutic drug levels; and to reduce side effects, ... technology that maintains stability of therapeutic proteins and peptides at human body temperature ...

CEL-SCI Developing Immune-Based Treatment Against Swine and Other H1N1 Flu Viruses Using Proprietary L.E.A.P.S. Technology

... it has gained from developing protective and therapeutic vaccines utilizing L.E.A.P.S. to develop a therapeutic treatment based upon the technology for people ... autoimmune diseases and allergies, are potential therapeutic or preventive sites for the application of ...

ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine

... DepoVax(TM) vaccine delivery system to advance a therapeutic HIV vaccine. "DepoVax(TM) will act as a vector ... developing a superior vaccine candidate for therapeutic use against HIV and AIDS," said Kalevi Reijonen, ... creating an urgent need for effective HIV therapeutic ....

Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement

... of a subset of antibodies in Morphotek's therapeutic antibody pipeline. The agreement will reserve ... optimized for affinity and/or titer, for therapeutic applications and high-titer manufacturing cell ... platform on the development and manufacturing of therapeutic antibodies for the treatment of cancer, ...
Other Contents
(Date:9/15/2014)... bonds are produced naturally across all kingdoms of life ... a broad range of biological activities. The presence of ... influence on their molecular properties. , One ... to find the late-stage, site-specific incorporation of a halogen ... sp C-H bond (one of the most inert chemical ...
(Date:9/15/2014)... coral reef ecologists fears that reef biodiversity may not ... we once thought. , In an international study published ... Excellence for Coral Reef Studies (Coral CoE) says we ... within reef ecosystems. , In coral reefs, just as ... keep the ecosystem safe and functioning. , Professor ...
(Date:9/15/2014)... assistant professor in the Department of Science and Technology ... Human Sciences at Virginia Tech, has won a 2014 ... study the prospects and problems of creating a global ... Japan,s Fukushima I Nuclear Power Plant in March 2011 ... viewed nuclear emergencies, Schmid said. Three of the plant,s ...
Breaking Biology News(10 mins):Pitt chemical biologist finds new halogenation enzyme 2Specialized species critical for reefs 2'Nuclear disasters don't respect national boundaries' 2
(Date:9/16/2014)... 2014. Kessler Foundation researchers have published a study ... the executive deficits found in individuals with multiple ... for executive deficits in multiple sclerosis? Evidence from ... ahead of print on August 18 by ... Victoria Leavitt, PhD, of the Manhattan Memory Center, ...
(Date:9/16/2014)... prospective study that compared patient-reported outcomes of a ... demonstrates that single fraction radiation therapy (SFRT) is ... (MFRT) when pain, function and quality of life ... the American Society for Radiation Oncology,s (ASTRO,s) 56th ... in patients, pain, function and degree of distress ...
(Date:9/16/2014)... presented at the ESMO 2014 Congress will be published ... to give you a first glimpse of what you ... the leading theme Precision Medicine in Cancer Care. , ... is now possible for an increasing number of cancers. ... a common goal --improved patient outcomes. This is the ...
(Date:9/16/2014)... 2014 The Pain Center of ... Ranking Arizona magazine, has selected Analance ™, ... , With TPC seeing hundreds of thousands of ... that was managed through “home grown” systems trying to ... clinical leadership teams. “Our current tools were not ...
(Date:9/16/2014)... September 16, 2014 Transparency Market Research, ... the global facial care market is expected to report ... report, titled ‘Facial Care Market (By Product Type - ... Cleansing Wipes, Serums and Masks and Others (fade creams, ... Growth, Trends and Forecast 2013 – 2019,’ is now ...
Breaking Medicine News(10 mins):Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 3Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 4Health News:ESMO 2014 Congress Preview 2Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 2Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 3Health News:Global Facial Care Market Will Report a CAGR of 6.9% between 2013 and 2019: Transparency Market Research 2Health News:Global Facial Care Market Will Report a CAGR of 6.9% between 2013 and 2019: Transparency Market Research 3
Other TagsOther Tags